SUMMARY: An interview with Dr. Timothy Cloughesy, UCLA Head of Neuro-oncology on the successful molecular treatment advances of Low Grade Gliomas; A discussion of which molecular targets are blocked to achieve excellent results using a new agent; Also discussed is an extension of this approach to Craniopharyngeoma treatment with other molecular blockers. Discussion of treatment options from HIC to LMIC. Molecular Rx not commercially available; Waiting, Surgery; Radiation Therapy, are all open to use world wide. Excellent present and future discussion; practical information for all locations globally.
